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Experimental IgE-mediated food allergy depends on
intestinal anaphylaxis driven by interleukin-9 (IL-9).
However, the primary cellular source of IL-9 and
the mechanisms underlying the susceptibility to
food-induced intestinal anaphylaxis remain unclear.
Herein, we have reported the identification of
multifunctional IL-9-producing mucosal mast cells
(MMC9s) that can secrete prodigious amounts of
IL-9 and IL-13 in response to IL-33, and mast cell
protease-1 (MCPt-1) in response to antigen and
IgE complex crosslinking, respectively. Repeated
intragastric antigen challenge induced MMC9 devel-
opment that required T cells, IL-4, and STAT6 tran-
scription factor, but not IL-9 signals. Mice ablated
of MMC9 induction failed to develop intestinal mas-
tocytosis, which resulted in decreased food allergy
symptoms that could be restored by adoptively
transferred MMC9s. Finally, atopic patients that
developed food allergy displayed increased intesti-
nal expression of Il9- and MC-specific transcripts.
Thus, the induction of MMC9s is a pivotal step
to acquire the susceptibility to IgE-mediated food
allergy.
INTRODUCTION
IgE-mediated food allergy is an immediate hypersensitivity re-
action that can affect multiple organ systems. Clinical symp-
toms of food allergy patients range from a mild skin reaction
to lethal shock (Boyce et al., 2010; Sicherer and Sampson,
2010). The anaphylactic response to ingested food antigens788 Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc.usually results from the activation of intestinal mast cells
(MCs) through food-specific IgE antibodies (Finkelman, 2007;
Galli and Tsai, 2012). However, it is perplexing as to why only
some patients and murine strains that acquire high amounts
of dietary allergen-specific IgE develop a severe immediate in-
testinal hypersensitivity response that can result in life-threat-
ening anaphylaxis.
The T helper 2 (Th2) cell cytokine interleukin (IL)-4 plays key
roles in promoting IgE antibody production and intestinal allergic
inflammation that are required for IgE-mediated food allergy
(Berin and Mayer, 2009; Brandt et al., 2009; Forbes et al.,
2008; Strait et al., 2011; Vickery et al., 2011). Mice deficient in
Il4 produce little IgE antibody and are resistant to developing
experimental food allergy (Brandt et al., 2009; Kweon et al.,
2000). In contrast, mice harboring an activating mutation of
the IL-4 receptor a chain (Il4raF709) produce elevated antigen-
specific IgE antibodies and are more susceptible to this disorder
(Mathias et al., 2011). In addition to IL-4, recent studies point to a
pivotal role for IL-9 in promoting intestinal mastocytosis and
driving experimental food allergy (Forbes et al., 2008; Osterfeld
et al., 2010). Repeated intragastric ovalbumin (OVA) challenge
fails to increase intestinal mastocytosis, serum mast cell prote-
ase-1 (MCPt-1), the incidence of allergic diarrhea, or hypother-
mia in sensitized IL-9- or IL-9R-deficient mice, even though
they produced OVA-specific IgE and IgG normally (Osterfeld
et al., 2010). In contrast, transgenic mice that constitutively
overexpress intestinal-specific IL-9 are more prone to develop
experimental food allergy (Ahrens et al., 2012; Forbes et al.,
2008; Osterfeld et al., 2010). Although these studies demon-
strate a distinctive role for IL-9 in promoting experimental food
allergy, the primary cellular source of IL-9 and the mechanisms
that underlie the susceptibility to intestinal anaphylaxis have
not been established. Herein, we report the identification of
IL-9-producing mucosal mast cells (MMC9s) and show that
the acquisition of MMC9s increases the susceptibility to IgE-
mediated experimental food allergy.
Figure 1. Lin– IL-9-Producing Cell Fre-
quency Correlates Positively with Suscepti-
bility to Experimental Food Allergy
(A, H, and I) Flow cytometric analysis of intracel-
lular IL-9 and IFN-g production by CD3+CD4+ T or
Lin cells (A) or frequencies of IL-9-producing cells
in LP of small intestine of indicated mouse strains
(H) or in the Lin fraction in the indicated tissues
from BALB/c mice (I) after six intragastric OVA
challenges.
(B–G) Indicatedmouse strains were sensitized and
challenged six times intragastrically with OVA
before measuring the indicated features of
experimental food allergy: incidences of allergic
diarrhea (B) and hypothermia (C), intestinal mast
cell numbers (D), MCPt-1 production (E), and
concentration of OVA-specific IgE (F) and OVA-
specific IgG (G).
Data in (A)–(I) are representative of three inde-
pendent experiments (n = 4 mice per group).
Fraction indicates incidences of allergic diarrhea
(B) and hypothermia (C). Error bars denote mean ±
SEM. *p% 0.05; **p% 0.01; ***p% 0.001. NS, not
significant. See also Figure S1.RESULTS
Mice Susceptible to Food Allergy Have Increased
Lineage– IL-9-Producing Cells
Just as allergen-sensitized patients have varying degrees of sus-
ceptibility to food allergens, OVA-sensitized murine strains differ
in their susceptibility to anaphylactic responses to ingested OVA
(Helm and Burks, 2002). Intestinal IL-9 production is important
for the development of experimental food allergy (Forbes et al.,
2008; Osterfeld et al., 2010), so we first examined and compared
the frequency of IL-9-producing cells among lamina propria (LP)
mononuclear cells in the small intestine of different immunized
murine strains. Although some CD3+CD4+ T cells produced
IL-9, most of the IL-9-producing LP cells in BALB/c, A/J, and
C3H/HeJ mice did not express cell lineage markers (Lin)
(Figure 1A). Among the examined murine strains, sensitized
BALB/c mice were the most likely to develop experimentalImmunity 43, 788–802,food allergy after six intragastric OVA
challenges, with BALB/c mice exhibiting
higher incidences of allergic diarrhea
and hypothermia (91.7%, 50.0%) as
compared to A/J (50.0%, 8.3%), C3H/
HeJ (12.5%, 0.0%), and C57BL/6 (0.0%,
0.0%) mice (Figures 1B and 1C). Notably,
murine strains that were more suscepti-
ble to experimental food allergy, as
manifested by allergic diarrhea and hypo-
thermia, also exhibited higher amounts of
intestinal mastocytosis (Figure 1D) and
serum MCPt-1 (which reflects mast cell
degranulation) (Figure 1E), whereas all
murine strains were capable of producing
considerable amounts of serum OVA-
specific IgE or IgG (Figures 1F and 1G).
BALB/c mice had the highest frequencyof intestinal Lin IL-9-producing LP cells (16.7% ± 2.0%,
mean ± SEM) andwere also themost susceptible strain to exper-
imental food allergy, whereas C57BL/6 mice lacked the Lin IL-
9-producing cell population and failed to develop experimental
food allergy (Figures 1A and 1B–1H). Immunized A/J and C3H/
HeJ strains had 6.0% ± 1.1% and 1.0% ± 0.3%, Lin IL-9-
producing LP cells, respectively, and were less susceptible to
developing experimental food allergy (Figures 1A and 1B–1H).
Similarly, a higher frequency of Linˉ IL-9-producing LP cells
(4.5%) was induced in sensitized CBA mice than those in
DBA2 (1.8%) and 129 (2.0%) mice after repeated challenges
(Figure S1A). Immunized CBA mice also displayed more pro-
nounced intestinal mastocytosis, produced more MCPt-1, and
were more susceptible to experimental food allergy, while
producing comparable amounts of OVA-specific IgE among
these murine strains (Figures S1B–1E). Anatomically, these
Lin IL-9-producing cells resided primarily within the LP, notOctober 20, 2015 ª2015 Elsevier Inc. 789
the intraepithelium of the small intestine, and very few of these
cells resided in the Peyer’s patch (PP), mesenteric lymph nodes
(MLNs), spleen, lung, or liver (Figure 1I). Together, these results
suggest an association of Lin IL-9-producing LP cells with the
susceptibility to experimental food allergy.
Innate MMC9s Are the Principal IL-9 Producers of Mast
Cell Lineage
A previous report demonstrated that type 2 innate lymphoid cells
(ILC2s) lack cell lineage markers and have the potential to pro-
duce IL-9 (Wilhelm et al., 2011). To determine whether these
intestinal Lin IL-9-producing cells were ILC2s, we generated
a monoclonal antibody against an IL-25 receptor component,
IL-17RB, the characteristic marker for ILC2s (Neill et al., 2010)
and employed BALB/c IL-4-eGFP (4GET) mice that can be
used to track ILC2s by their GFP expression in our murine model
of food allergy. Two dominant LinGFPhi cell populations were
identified: LinGFPhiIL-17RB cells and LinGFPhiIL-17RB+
cells (Figure 2A). ELISA analyses revealed that purified Lin
GFPhiIL-17RB cells were the population responsible for
secreting prodigious amounts of IL-9 (2.0 pg/ml per cell) and
other Th2-cell-associated cytokines, including IL-4 and IL-13,
in lesser amounts after PMA plus ionomycin stimulation (Fig-
ure 2B). In contrast, the LinGFPhiIL-17RB+ cell population pro-
duced considerable amounts of IL-5 (0.8 pg/ml per cell), as well
as lesser amounts of IL-13 and IL-4, but little IL-9 (< 0.01 pg/ml
per cell) (Figure 2B). Both LinGFPhi cell populations produced
undetectable interferon-g (IFN-g) and IL-17 (Figure 2B). In addi-
tion, intestinal CD3+CD4+ Th2 cells that displayed increased
expression of IL-17RB, ST2 (IL-33 receptor), and GFP, but not
CD3+CD4+IL-17RBST2GFP T cells, could also produce
moderate amounts of IL-9 (0.05 pg/ml per cell) as well as
IL-4, IL-5, and IL-13 (Figures 2A and 2B and data not shown).
These results demonstrate that LinGFPhiIL-17RB, not Lin
GFPhiIL-17RB+ cells or CD4+ Th2 cells, are the principal IL-9 pro-
ducers in mice susceptible to experimental food allergy.
To better understand the lineage of these LinGFPhi cells, we
performed detailed cellular and molecular characterization. The
purified IL-9-producing LinGFPhiIL-17RB cells were found to
express c-Kit, FcεRIa, ST2, Thy1.2, major histocompatibility
complex class II (MHCII), and CD86, but not IL-2Ra, IL-7Ra,
Sca-1, CD23, CCR3, Siglec-F, or IL-3Ra (CD123) (Figure S2A
and data not shown), implying a MC lineage phenotype (Kita-
mura, 1989). Notably, the majority (>90%) of LinGFPhiIL-
17RBc-Kit+ST2+ cells did not express surface b7integrin, an
adhesion molecule that characterizes previously described in-
testinal mast cell progenitors (MCPs) (Figure 2C; Chen et al.,
2005; Gurish et al., 2001). Intracellular cytokine analysis demon-
strated that the principle IL-9 producers were the b7integrinlo
subset of LinGFPhiIL-17RBc-Kit+ST2+ cells, although both
b7integrinhi and b7integrinlo subsets could produce IL-13 (Fig-
ure 2D). Consistently, both cell subsets expressed Il13 transcript
(>104-fold), but only b7integrinloLinGFPhiIL-17RBc-Kit+ST2+
cells expressed very large amounts of Il9 transcript (>105-fold),
compared to naive CD4+ T cells (Figure 2E). Similar to bone-
marrow-derived mast cells (BMMCs), both b7integrinhi and
b7integrinlo subsets of LinGFPhiIL-17RBc-Kit+ST2+ cells
expressed Gata1 (>103-fold), Gata2 (>103-fold), and Mcpt1
(>103-fold), not Rora, Gata3, Mcpt8, and Mcpt11 transcripts790 Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc.(Figure 2E and data not shown). Notably, stimulation with
IL-33 plus stem cell factor (SCF) and IL-3 ex vivo triggered the
b7integrinlo, but not the b7integrinhi, subset of LinIL-17RBc-
Kit+ST2+ cells to produce large amounts of IL-9 and IL-13, with
considerably less IL-5 and no IFN-g (Figure 2F). Purified IL-9-
producing b7integrinloLinIL-17RBc-Kit+ST2+ cells produced
comparable amounts of histamine as BMMCs and contained
10-fold more intracellular MCPt-1 than did BMMCs, while
possessing similar efficacy of MCPt-1 secretion as BMMCs in
response to IgE-bound FcεRIa complex crosslinking (Figures
2G and S2C). Cytology and electron microscopy revealed that
both the b7integrinhi and b7integrinlo subsets of LinIL-
17RBc-Kit+ST2+ cells resembled mucosal MCs in their small
size, large nuclei, scanty cytoplasm, and small number of meta-
chromatic granules (Figures 2H and 2I; Chen et al., 2005; Gurish
et al., 2001). Notably, only the b7integrinhi, not b7integrinlo,
subset of LinIL-17RBc-Kit+ST2+ cells vigorously expanded
(>450-fold) during 15 days of culture with IL-3 and SCF
(Figure S2B). Furthermore, the agranular IL-9-producing
b7integrinloLinIL-17RBc-Kit+ST2+ cells rapidly developed
into granular MCs and acquired b-hexoaminidase activity but
lost robust IL-9-producing capability after IL-3 plus SCF culture
(Figures S2D–S2F). These findings suggest that b7integrinhi
LinIL-17RBc-Kit+ST2+ cells are the intestinal MCPs (Gurish
and Austen, 2012) and that b7integrinloLinIL-17RBc-Kit+ST2+
cells are the intestinal IL-9-producing MCs, which we term IL-9-
producing mucosal mast cells or MMC9s.
In contrast to MMC9s, LinGFPhiIL-17RB+ cells expressed
characteristic ILC2 markers, including ST2, IL-7Ra, IL-2Ra,
Thy1.2, MHCII, CD86, and ICOS, but not c-Kit or FcεR (Fig-
ure S3A). Purified LinGFPhiIL-17RB+ cells underwent an expan-
sion and produced large amounts of IL-5 and IL-13, along with a
small amount of IL-9 after culture with IL-25 and/or IL-33 in the
presence of IL-7; in contrast, MMC9s, which lacked IL-17RB,
did not respond to these stimuli and perished (Figure S3B
and data not shown; Wilhelm et al., 2011). Moreover, systemic
IL-25 administration induced an expansion of LinGFPhiIL-
17RB+c-Kitˉ cells but not MMC9s (Figures S3C and S3D). Puri-
fied LinGFPhiIL-17RB+c-Kitˉ cells displayed the characteristic
ILC2 molecular profile, including large amounts of Il5 (>103-
fold), Il13 (>106-fold), and transcription factor Gata3 (>103-fold)
and Rora (>104-fold), and moderate amounts of Il9 (<103-fold)
transcripts (Figure 2E and data not shown). In this regard, the
LinGFPhiIL-17RB+c-Kitˉ cells detected in our murine model of
food allergy appeared identical to the intestinal IL-25-responding
ILC2s that have previously been shown to elicit protective
immunity against intestinal worm infection (Moro et al., 2010;
Neill et al., 2010; Price et al., 2010; Saenz et al., 2010). In
contrast, MMC9s did not respond to IL-25 stimulation in vitro
and in vivo and are distinct from both ILC2s and the previously
reported IL-25-elicited c-Kitint-GFP+ multipotent progenitor
(MPPtype2) (Saenz et al., 2010). Furthermore, RNA-seq analyses
and comparison of purified hematopoietic cell lineages revealed
that in addition to MMC9-specific genes (1), MMC9s expressed
MC lineage-associated transcripts (2) that were clustered
closely with those by MCPs, mature MCs, and BMMCs as well
as Th2-cell-mediated immune response-associated transcripts
(3) expressed by intestinal CD4+ Th2 cells and ILC2s (Fig-
ure S3E). Thus, distinct from ILC2s, MMC9s are the type 2
(legend on next page)
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cytokine-producing innate cells with MC-lineage molecular
signatures.
Bone Marrow MCPs Give Rise to Intestinal MMC9s
To examine theMC lineage origin of intestinal MMC9s in vivo, we
first established a reconstitution model of experimental food
allergy by adoptively transferring bone marrow (BM) cells from
4GET mice into OVA-sensitized BALB/c mice 1 day after sub-
lethal irradiation (protocol diagramed in Figure S4A). After the
second sensitization and repeated intragastric OVA challenge,
transferred BM cells replenished the majority of MCPs and
MMC9s, which were marked with GFP, in the irradiated recipi-
ents (Figure S4B). In contrast, most CD4+IL-17RB+ST2+ Th2
cells were derived from the sensitized recipients as shown
by their lack of GFP expression (Figure S4C). Compared to re-
constituted mice that were challenged with saline only, repeated
intragastric OVA challenge triggered a substantial increase
in donor-derived (>95% GFPhi) MMC9s and recipient-derived
(>98% GFP) CD4+ Th2 cells (Figures S4B and S4C). This is
probably because donor-derived hematopoietic progenitors
will reconstitute innate MC lineage within 2 weeks, whereas
de novo T cell generation after thymus engraftment requires
>2 months (Spangrude and Scollay, 1990). Indeed, WT BM pro-
genitors from Thy1.1+ BALB/c mice could reconstitute most of
intestinal MMC9s that expressed congenic marker Thy1.1hi/lo
(>95%) in the irradiated WT Thy1.2+ BALB/c recipients, in which
most of intestinal CD4+ T cells expressed Thy1.2 (>98%)
after repeated intragastric OVA challenge (Figure S4D). Next,
we showed that purified BM MCPs (defined as LinLy-
6cFcεRIaCD41CD71FLK2CD150c-Kit+b7integrin+ cells)
(Franco et al., 2010) from 4GET mice gave rise to intestinal
GFP-expressing MCPs and MMC9s, and repeated intragastric
OVA challenge triggered a significant increase of both MMC9s
and MCs in the sensitized recipients, which eventually devel-
oped symptoms of experimental food allergy (Figures 3A–3C).
Furthermore, the blockade of intestinal b7integrinhi MCP recruit-
ment by anti-a4b7integrin mAb significantly reduced intestinal
MCP and MMC9 frequency and MC number. Consequently,
these reconstituted recipients failed to develop experimental
food allergy, despite normal OVA-specific IgE production (Fig-
ures 3D–3F). Additionally, sorted single intestinal b7hi MCPs
had the potential to develop into MMC9s that displayed b7loc-
Kit+ST2+FcεRIa+ phenotype and upregulated Il9, Il13, and
Mcpt6, while maintaining Gata2 expression after culture withFigure 2. Lin–GFPhiIL-17RB–c-Kit+ST2+b7integrinlo Cells Are the Multi-
(A and B) Detection of (A) and measurements of (B) indicated cytokines secreted
GFP+IL-17RB+ and GFPIL-17RB subsets of CD3+CD4+ T cells in LP of small i
(C and D) Detection of (C) and flow cytometric analysis of indicated intracellular c
17RBc-Kit+ST2+ cells.
(E) Expression of the indicated genes by purified intestinal b7integrinlo and b7
marrow-derived mast cells (BMMCs), ILC2s, and CD4+GFP+IL-17RB+ Th2 cells
PCR using primers referenced in the Experimental Procedures.
(F) Measurement of indicated cytokine production by purified intestinal b7integrinl
with SCF plus IL-3 in the presence or absence of IL-33.
(G) Measurement of intracellular MCPt-1 within purified LinIL-17RBc-Kit+ST2
secretion after IgE crosslinking.
(H and I) Giemsa staining (H) and electron microscopic analysis (I) of purified Lin
Gene expression data are expressed as relative fold difference (E). Scale bars re
pendent experiments. Error bars denote mean ± SEM. **p% 0.01. NS, not signi
792 Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc.SCF, IL-4, TGF-b, and IL-33 (Figure S2G and data not shown).
Colony-forming cell assays showed that all of their progeny col-
onies derived from single MMC9s displayed a mature MC
phenotype and morphology, although MMC9s had reduced
capacity (<10%) to generate compact colonies, compared to
b7hi MCPs (>40%) (Figure S2H and data not shown). Given the
cellular and molecular characteristics of MCPs, MMC9s, and
MCs (Figures 2, 3, and S2–S4), these results suggest that intes-
tinal b7integrinhi MCPs of BM origin have the potential to prolif-
erate and develop into b7integrinlo MMC9s, which can mature
into mucosal MCs with increased granular enzyme activity but
reduced IL-9 production.
Ingested Antigens Induce Concomitant MMC9 and CD4+
Th2 Cell Accumulation
We compared the occurrence in the LP of the principal cell types
that may be involved in the development of experimental food
allergy: MCPs, MMC9s, CD4+ Th2 cells, ILC2s, and basophils
(c-KitloFcεRIa+DX5+IL-3Rb+). Although MCPs and MMC9s rep-
resented only 0.3% and 0.5% of total mononuclear cells
in the small intestine of naive or intraperitoneally sensitized
BALB/c mice, respectively, repeated intragastric OVA challenge
induced a considerable accumulation of MMC9s (9%) in
sensitized mice, whereas MCPs remained a minor population
(Figures 4A and 4B). Concurrently, CD4+IL-17RB+ Th2 cells
also increased (4%) compared to naive mice (0.5%) (Figures
4A and 4B). Importantly, the concomitant increase of MMC9s
and CD4+IL-17RB+ Th2 cells positively correlated with increased
features of experimental food allergy: allergic diarrhea, intestinal
MC number, serum MCPt-1, OVA-specific IgE and IgG, and
histamine (Figures 4A–4F, and data not shown). Furthermore,
analysis of seven murine strains showed that the concomitant
increase of MMC9 and CD4+IL-17RB+ Th2 cells was much
greater in murine strains that were prone to develop experi-
mental food allergy (i.e., BALB/c, A/J, and CBA) than in those
that were resistant to developing experimental food allergy
(i.e., C3H/HeJ, DBA2, 129, and C57BL/6) (Figures 1A–1H, 4G,
and S1). In contrast, the frequencies of ILC2s (2.0%) and baso-
phils (<0.1%) remained constant even after the examinedmurine
strains were subjected to stimuli that induce intestinal anaphy-
laxis (data not shown). Similarly, skin-sensitized mice by vitamin
D3 analog (Calcipotriol) also developed strong MMC9 (>3.5%)
and CD4+ Th2 (>2%) immune response, resulting in pronounced
intestinal mastocytosis and increased MCPt-1 production afterfunctional IL-9-Producing Mucosal Mast Cells
by two dominant LinGFPhi cell fractions that are IL-17RB and IL-17RB+, and
ntestine of IL-4-eGFP (4GET) mice after six intragastric OVA challenges.
ytokines by (D) b7integrinlo (b7lo) and b7integrinhi (b7hi) subsets of LinGFPhiIL-
integrinhi subsets of LinGFPhiIL-17RBc-Kit+ST2+, in-vitro-generated bone-
from mice with active allergic diarrhea was analyzed by quantitative real-time
o and b7integrinhi subsets of LinGFPhiIL-17RBc-Kit+ST2+ after 3 days culture
+b7integrinlo or bone-marrow-derived mast cells (BMMCs) and their MCPt-1
IL-17RBc-Kit+ST2+b7integrinlo cells.
present 20 mm (H) or 2 mm (I). Data in (A)–(G) are representative of three inde-
ficant. See also Figures S2 and S3.
Figure 3. Blockade of Intestinal b7hi MCP Recruitment from Bone Marrow Results in the Failure of MMC9 Induction
Detection and frequency of donor-derived MMC9s (LinGFP+ST2+c-Kit+ b7integrinlo) and MCPs (LinGFP+ST2+c-Kit+b7integrinhi), and mast cell (MC) number
(A, B, D, E), and serumMCPt-1 and OVA-IgE titers, and diarrhea incidence (C, F) of irradiated recipient BALB/c mice reconstituted with sorted bone marrowmast
cell progenitors (LinLy-6cFcεRIaCD41CD71FLK2CD150c-Kit+b7integrin+ cells) from IL-4-eGFP (4GET) mice (A–C) or received anti-a4b7integrin
(LPAM-1) or isotype-matched mAb and reconstituted with wild-type bone marrow progenitors from IL-4-eGFP (4GET) mice (D–F) 1 day before second sensi-
tization and six intragastric OVA challenges. Data represent one of three independent experiments (n = 6 mice per group) (A–C) or one of two independent
experiments (n = 4 mice per group) (D–F). LP, laminar propria. Error bars denote mean ± SEM. *p < 0.05, **p < 0.01. NS, not significant. See also Figure S4.repeated intragastric OVA challenge (Figures S5A–S5D). How-
ever, we failed to detect significant induction of MMC9s (<1%)
and CD4+ Th2 cells (<1%) in cholera toxin (CT)-sensitized
C3H/HeJ or BALB/c mice that displayed few intestinal MCnumbers and produced lowMCPt-1 titer after repeated intragas-
tric OVA challenge (Figures S5E–S5G). These results demon-
strate that repeated oral antigen challenge triggers substantial
accumulations of MMC9s and CD4+ Th2 cells, but not MCPs,Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc. 793
Figure 4. MMC9s and CD4+ Th2 Cell Frequencies Correlate Positively with Susceptibility to Experimental Food Allergy
(A–F) Detection (A) and frequency of MMC9s (A-F), MCPs (A, B), and CD4+IL-17RB+ Th2 cells (A, B) in LP of small intestine of naive, sensitized, or BALB/c mice
after indicated times of intragastric OVA challenge. Serum samples (C, E, F) or intestinal tissue (D) were collected for measurement of indicated features of
experimental food allergy, including allergic diarrhea incidence (B), MCPt-1 production (C), intestinal mast cell numbers (D), and titers of OVA-specific IgE (E) and
OVA-specific IgG (F).
(G) Frequency of indicated cell populations in LP of small intestine of indicated mouse strains after six intragastric OVA challenges.
Spearman’s rank coefficients and two-tailed p values were used to quantify the correlations between the indicated features of experimental food allergy and
frequency of MMC9s (C–F). Fractions indicate incidence of allergic diarrhea (B). Data in (A)–(G) are representative of three independent experiments (n = 4 mice
per group). Error bars denote mean ± SEM. *p% 0.05; **p% 0.01; ***p% 0.001. NS, not significant. See also Figure S5.
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ILC2s, or basophils in the small intestine of sensitized mice and
that the concomitant increase of MMC9s and CD4+ Th2 cells
correlates positively with susceptibility to and severity of exper-
imental food allergy.
MMC9 Induction Requires CD4+ Th2 Cells
To understand the requirements for MMC9 induction, we first
analyzed genetically modified mice that were resistant to devel-
oping experimental food allergy. Compared to WT mice, sensi-
tized BALB/c IL-4-, IL-4Ra-, STAT6-, or Rag-2-deficient mice
and T-cell-deficient nude mice were less competent to recruit
MCPs, failed to develop MMC9s, and subsequently were resis-
tant to develop features of food allergy after repeated intragastric
OVA challenge (Figures 5A–5C and data not shown). Anti-CD4
mAb ablation of T cells before challenge suppressed MMC9 in-
duction but not MCP recruitment in sensitized mice and pre-
vented the development of experimental food allergy (Figures
5D–5F). Analysis of the reconstitution model of experimental
food allergy revealed that the reconstituted, immunized wild-
type recipients, which acquired significant accumulations of
GFPhi MMC9s and GFPCD4+ Th2 cells, eventually developed
features of experimental food allergy (Figures 5G–5I). In contrast,
Stat6/ recipients, which lacked recipient-derived GFPCD4+
IL-17RB+ Th2 cells, recruited fewer donor-derived GFPhi MCPs
and failed to develop GFPhi MMC9s and any characteristics of
experimental food allergy (Figures 5G–5I). Collectively, these re-
sults demonstrate that the induction of MMC9s requires T cells
and IL-4 signals and that an intact Th2 cell microenvironment,
provided by CD4+ Th2 cells, induces MMC9s that promote
experimental food allergy.
IL-9 Signals Promote MMC9 Expansion and Intestinal
Mastocytosis
IL-9 plays an important role in MC development and growth
(Goswami and Kaplan, 2011), so we examined the requirements
of IL-9 and IL-9R in the MMC9 induction. Although the MCP and
MMC9 accumulations occurred normally, many fewer sensitized
IL-9- and IL-9R-deficient mice developed a diarrheal response
and had significantly reduced intestinal MC number and serum
MCPt-1, despite normal OVA-specific IgE titers (Figures 6A–
6E). The failure to develop experimental food allergy in Il9/
and Il9r/ mice could be restored after the reconstitution with
WT BM cells (Figures S6A–S6C), because BM MCPs purified
from 4GET mice could reconstitute GFP+ MMC9s that pro-
moted intestinal mastocytosis in Il9/ recipients (Figure S6D).
In contrast, IL-9- or IL-9R-deficient BM cells failed to restore
the susceptibility to developing experimental food allergy in the
irradiated 4GET recipients, despite significant generations of
GFPMMC9s deficient of IL-9 or IL-9R (Figures 6F–6I). Addition-
ally, IL-9R-deficient BM cells were less efficient than WT or IL-9-
deficient BM cells to reconstitute GFPMMC9s (Figures 6F–6I),
possibly due to alternative IL-9 sources produced by recipient’s
CD4+ Th2 cells and/or ILC2s that were sufficient to enhance
MMC9 expansion (Figures 6F–6H, 1A, and 2E). Finally, reconsti-
tution with purified WT, not IL-9-deficient, MMC9s could directly
promote intestinal mastocytosis and restore the propensity to
develop experimental food allergy in sensitized recipients that
lacked an alternative source of IL-9 (Figure S6E). These results
suggest that IL-9 and IL-9R are dispensable for MMC9 develop-ment but are necessary for effective expansion of MMC9s that
promote intestinal mastocytosis and susceptibility to experi-
mental food allergy in an IL-9-dependent autocrine manner.
MMC9 Induction Augments Intestinal Mastocytosis that
Drives Experimental Food Allergy
To directly demonstrate that MMC9 induction is a key step for
the amplification of intestinal mastocytosis that promotes the
development of experimental food allergy, we treated OVA-
sensitized BALB/c WT mice with anti-FcεRIa mAb before and
during the course of repeated intragastric OVA challenge. Anti-
FcεRIa mAb treatment efficiently ablated MCPs and MMC9s
as evidenced by a 90% decrease in Lin IL-9-producing cells
(Figures 7A and 7B). The loss of MCPs and MMC9s was associ-
ated with decreased MC number and goblet cell hyperplasia,
and serum MCPt-1, and the failure to develop allergic diarrhea
after repeated intragastric OVA challenge (Figures 7B–7D).
Importantly, transfer of purified MMC9s to mice that had been
treated with anti-FcεRIa mAb accelerated restoration of the
ability to develop intestinal mastocytosis and promoted their
development of allergic diarrhea after repeated intragastric
OVA challenges (Figures 7E and 7F). Compared to WT mice,
much fewer intestinal MCPs and MMC9s were induced in sensi-
tized Fcer1a/mice, which consequently exhibited less intesti-
nal mastocytosis, produced fewer MCPt-1, and failed to develop
food allergy (Figures S7A–S7C). These results further demon-
strate that MMC9s drive intestinal mastocytosis to promote the
susceptibility to experimental food allergy in an FcεR-dependent
manner.
Food Allergy Patients Display Increased Expression of
Il9 and Mast Cell-Specific Transcripts
To evaluate a biological relevance of MMC9 induction in human
food allergy, we analyzed the expression of MMC9 signature
transcripts in the duodenum of patients who had defined food
allergy characteristics (Table S1). Notably, expression of Il9
and Il13 and mast cell transcripts, such as carboxypeptidase
A3 (Cpa3), tryptase, and chymase, were significantly increased
in the duodenum of food allergy patients than those in control
subjects (Figure 7G). These results suggest that increased
expression of both Il9- and MC-specific transcripts in the small
intestine might be associated with atopic patients that devel-
oped food allergy.
DISCUSSION
The prevalence of food-induced allergic disorders has
increased substantially in industrialized countries over the past
decade (Gupta et al., 2011). Current knowledge cannot explain
why only some individuals who have high titers of dietary
allergen-specific serum IgE develop life-threatening intestinal
anaphylaxis. In this study, we have reported the identification
of IL-9-producing mucosal mast cells, MMC9s, which were
preferentially induced in murine strains susceptible to food
allergy. MMC9s secreted large amounts of IL-9 and IL-13 in
response to IL-33, and MCPt-1 protein and histamine in
response to IgE-bound FcεR complex cross-linking by antigens.
Given their anatomical location, characteristics, and function,
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Figure 5. STAT6 Signaling and T Cells Are Required for MMC9 Induction that Promotes Experimental Food Allergy
(A–F) Detection (A, D) and frequency (B, E) of MMC9s (Linc-Kit+ST2+b7integrinlo) andMCPs (Linc-Kit+ST2+b7integrinhi) andmeasurement of indicated features
of experimental food allergy after six intragastric OVA challenges (B, C, E, F) in wild-type BALB/c or indicated gene-deficient murine strains (A–C) or sensitized
wild-type BALB/c treated with anti-CD4 or isotype control mAbs 1 day before first and fourth intragastric OVA challenges (D–F).
(G–I) Detection (G) and frequency (H) of MMC9s, MCPs, and CD4+ Th2 cells andmeasurement of indicated features of experimental food allergy (H, I) in indicated
sub-lethally irradiated recipient strains reconstituted with BM progenitors from WT 4GET mice.
Data in (A)–(I) represent one of three independent experiments (n = 4 mice per group). Fractions indicate incidence of allergic diarrhea (C, F, I). Error bars denote
mean ± SEM. *p% 0.05; **p% 0.01; ***p% 0.001. NS, not significant.
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Figure 6. MMC9s Can Be Induced in IL-9- or IL-9R-Deficient Mice but Fail to Promote Experimental Food Allergy
(A–E) Detection of LinIL-17RBc-Kit+ST2+ cells (A), flow cytometric analysis of indicated intracellular cytokine production by LinIL-17RB cells (B), staining for
intestinal mastocytosis (C), and frequency of MMC9s (Linc-Kit+ST2+b7integrinlo) and MCPs (Linc-Kit+ST2+b7integrinhi) (D) and measurement of indicated
features of experimental food allergy (D, E) in wild-type BALB/c or indicated gene-deficient murine strains after six intragastric OVA challenges.
(F–I) Detection (F, G) and frequency (H) of donor-derived MMC9s (Linc-Kit+ST2+b7integrinloGFP) and MCPs (Linc-Kit+ST2+b7integrinhiGFP), and mea-
surement of indicated features of experimental food allergy (H, I) in sub-lethally irradiated 4GET recipients reconstituted with BM progenitors from indicated
murine strains.
Data represent one of three independent experiments (n = 4 or 8 mice per group). Scale bars represent 20 mm (C). Error bars denote mean ± SEM. **p% 0.01. NS,
not significant. See also Figure S6.
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Figure 7. MMC9s Drive Intestinal Mastocytosis and Il9 Transcript Expression Is Increased in Food Allergy Patients
(A–D) Detection (A) and frequency (B) of MMC9s and MCPs, measurement of indicated features of experimental food allergy (B, C), staining of intestinal mas-
tocytosis and goblet cell hyperplasia (D), from mice treated with anti-FcεRIa or isotype control mAbs.
(E and F) Numbers of intestinal mast cells (E) and incidence of allergic diarrhea (F) in anti-FcεRIa antibody-treated mice reconstituted with purified MMC9s or
saline only, or treated with saline plus anti-FcεRIa before re-challenge with OVA intragastrically twice (E) or indicated times (F) (12 mice per group).
(G) Expression of the indicated genes by duodenal biopsies from control and food allergy subjects was analyzed by quantitative real-time PCR using primers
referenced in the methods.
Data in (A)–(D) represent one of three independent experiments (n = 4 mice per group). Gene expression data are expressed as relative fold difference as
described in (G). Error bars denote mean ± SEM. Scale bars represent 20 mm (D) and 100 mm (D, the corner insets). *p% 0.05; **p% 0.01. See also Figure S7.
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inflammation and perpetuates anaphylactic response to aller-
genic dietary proteins.
Several observations support our view that MMC9s are
multi-functional and possess unique characteristics of mucosal
MCs. (1) MMC9s display strong expression of Gata1, Gata2,
and the mucosal MC-related chymase transcript, Mcpt1 and
Mcpt4, and the connective tissue MC-related tryptase tran-
script, Mcpt6 (Miller and Pemberton, 2002; Welle, 1997). (2)
MMC9s originate from bone marrow MCPs. (3) MMC9s exhibit
a small progenitor-like morphology with few metachromatic
granules in their scanty cytoplasm, the defining mucosal MC
characteristics (Beaven, 2009). (4) MMC9s mature into granular
MCs, but possess very poor proliferative capacity. (5) MMC9s
produce prodigious amounts of IL-9, the key cytokine for the
proliferation, maturation, and activation of MCs (Goswami and
Kaplan, 2011; Renauld et al., 1995). (6) MMC9s are distinct
from other IL-4- and IL-13-producing non-lymphoid cells
(MCs, basophils, and eosinophils), which develop normally in
STAT6- or IL-4Ra-deficient mice (Gessner et al., 2005), inas-
much as MMC9 development requires the IL-4 and STAT6
signals. (7) IL-9 and IL-9R signals are important to establish
pulmonary and intestinal mastocytosis (Osterfeld et al., 2010;
Townsend et al., 2000) but are dispensable for MMC9 induc-
tion. Thus, MMC9s might represent Th2 cytokine-producing
innate cells that follow the common myeloid progenitor (CMP)
and granulocyte-macrophage progenitor (GMP) developmental
pathway, paralleling ILC2s, a member of ILC family that de-
velops through the common lymphoid (CLP) pathway (Arinobu
et al., 2005).
The interplay between MMC9s and CD4+ Th2 cells appears
to be a key mechanism that governs the susceptibility to and
severity of experimental food allergy. Among seven examined
murine strains, the frequencies of intestinal b7hi MCPs
(0.2%) and b7lo MMC9s (0.1%) were initially comparable
before sensitization, except C57BL/6 mice that fail to develop
MMC9s. After repeated challenge, MMC9 and CD4+ Th2 cell
frequencies were concomitantly higher in sensitized BALB/c,
A/J, and CBA mice than those in DBA2, 129, and C3H/HeJ
mice. Consequently, BALB/c, A/J, and CBA mice exhibited
increased intestinal MC numbers, serum MCPt-1 titers, and
the propensity to develop experimental food allergy, despite
the fact that murine strains DBA2, 129, and CBA share the
same MHC H2 haplotype with BALB/c (H2d), C57/B6 (H2b),
and C3H/HeJ (H2k), respectively. Finally, mice ablated of or
deficient in T cells or IL-4 signaling had reduced capacity to
accumulate intestinal MCPs and failed to develop MMC9s.
Thus, the ability of murine strains to mount the intestinal
CD4+ Th2-cell-mediated immune response to ingested dietary
antigens, not their MHC H2 haplotype, correlated positively
with MMC9 frequency, and consequently, susceptibility to
food allergy. Whether our findings of MMC9s and its
dependence on CD4+ Th2 cells pertain to helminth-induced
T-cell-dependent mucosal MCs and IL-9 dependence of the
protective response to Trichinella spiralis infection remains
to be investigated (Angkasekwinai et al., 2013; Dillon and
MacDonald, 1986; Liu et al., 2013; Ruitenberg and Elgersma,
1976; Urban et al., 2000).
Several murine models have been developed in an attempt
to understand the immunological mechanisms underlying thesusceptibility of food allergy. In addition to adjuvant alum that in-
duces a strong allergic sensitization, administration of CT intra-
gastrically could also break oral tolerance and induce elevated
histamine, IgE, and IgG1 titers, resulting in systemic anaphy-
lactic responses to ingested allergen, which occurred selectively
in C3H/HeJ strain (Li et al., 1999; Morafo et al., 2003). In contrast
to sensitization via alum adjuvant, repeated intragastric OVA
challenge failed to induce strong MMC9 (<1%) and CD4+ Th2
(<1%) immune responses in CT-sensitized C3H/HeJ or BALB/c
mice, despite inducing a strong humoral immune response.
Consequently, much fewer intestinal MC numbers and serum
MCPt-1 titers (15 cells/mm2 and 2 mg/ml) were induced in
CT-sensitized C3H/HeJ or BALB/c mice than those (400
cells/mm2 and 20 mg/ml) detected in alum-sensitized BALB/c
mice (Li et al., 1999; Morafo et al., 2003). Additionally, a signifi-
cant increase of intestinal MMC9 frequency, mucosal MC
number, and serum MCPt-1 titer could be observed in the
vitamin D3 analog (Calcipotriol)-, not vehicle-, sensitizedmice af-
ter repeated intragastric OVA antigen challenge. These findings
suggest that MMC9 induction can occur in mice sensitized
with ‘‘atopic-promoting’’ adjuvants, such as alum and vitamin
D3 analog, which preferentially prime Th2 cell immune response.
Importantly, the finding that Fcer1a/ mice exhibited reduced
intestinal MCP recruitment, MMC9 induction, and MC number
and failed to develop food allergy further underscores that the
alum-sensitized model of food allergy is dependent on the clas-
sical IgE-mediated MC and FcεR pathway (Ahrens et al., 2012;
Osterfeld et al., 2010). In contrast, the genetic susceptibility
(Morafo et al., 2003), Tlr4 mutation (Bashir et al., 2004), and/or
the alternative pathway mediated by IgG and FcgR complex
(Smit et al., 2011) have been implicated in contributing to the
susceptibility of C3H/HeJ strain to systemic anaphylaxis after
CT sensitization.
Because MMC9s have limited proliferative potential, it is
plausible to propose that crosslinking of IgE-bound FcεR com-
plexes by dietary antigens results in a strong proliferation of
BM-derived MCPs, which then develop into MMC9s in the
presence of intestinal CD4+ Th2 cells induced by ingested
food allergens. These induced MMC9s might later mature
into granular MCs or alternatively promote MCP maturation
directly, in an IL-9-dependent manner. Additionally, our find-
ings also suggest that MMC9s amplify intestinal mastocytosis
by producing IL-9 in response to alarmin IL-33 and by
releasing proteases in response to dietary antigen crosslinking
of IgE-bound FcεR complexes; consequently, they serve as
innate myeloid helper cells to promote the development of
IgE-mediated food allergy. Indeed, the association between
increased numbers of duodenal IgE-positive MCs and food
allergy has been observed in clinical studies (Bengtsson
et al., 1991; Caffarelli et al., 1998). Furthermore, the expression
of both Th2 cytokine Il9 and Il13 and mast-cell-specific
Cpa3, tryptase, and chymase transcripts were significantly
increased in the duodenum of atopic patients that developed
food allergy. Understanding the factors that predispose murine
strains to break oral tolerance and to initiate collaboration
between innate MMC9s and adaptive CD4+ Th2 cells in
response to dietary antigens should provide insights into the
design of therapeutic strategies for IgE-mediated food allergy
in humans.Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc. 799
EXPERIMENTAL PROCEDURES
Food Allergy Patient Characteristics
Duodenal biopsies were obtained from patients with food allergy defined by (1)
clinical history of food anaphylaxis (FA), (2) a positive skin prick test with the
food allergens, and/or (3) a positive IgE-RAST to food allergens. Additionally,
the patient samples of both control and FA groups were selected when their
endoscopy biopsies did not meet the criteria for active eosinophil-associated
gastrointestinal disorders (EGID) based on the histological definition (>15 peak
eosinophils/HPF in the esophagus, >30 eosinophils in five separate HPF in the
stomach, and >normal values in the duodenum). All patients and/or family con-
sented for research participation and the study was approved by the Cincinnati
Children’s Hospital Medical Center (CCHMC) Institutional Review Board.
Mice
BALB/c, A/J, C3H/HeJ, C57BL/6J, Il4/ (stock number 002496), Il4ra/
(stock number 003514), Stat6/ (stock number 002828), athymic nude mice
(stock number 000711), Rag2/ (stock number 008338), Fcer1a/ (stock
number 005629), and IL-4-IRES-eGFP (4GET) (stock number 004190) mice
were purchased from the Jackson Laboratory. Il9/ and Il9r/ mice were
provided by Andrew McKenzie and Jean-Christophe Renauld, respectively.
All genetically modified mice were backcrossed to BALB/c background for
more than ten generations. All experimental procedures were approved
by the Institutional Animal Care and Use Committee of Cincinnati Children’s
Hospital Medical Center.
Lamina Propria Mononuclear Cell Isolation
Small intestines were cut longitudinally and incubated in HBSS with 5 mM
EDTA at 4C for 30min before vortexing to remove epithelial cells. The remain-
ing tissues were minced and digested with 2.4 mg/ml collagenase A (Roche)
and 0.2 mg/ml DNaseI (Roche) at 37C for 30 min. After removal of tissue
debris, liberated cells suspended in 44% Percoll were loaded above 67%
Percoll before centrifugation. LP cells were collected from the interface
between 44% and 67% Percoll.
Flow Cytometric Analysis and Cell Sorting
LP cells from small intestines of 4GET or BALB/c mice were first stained with
phycoerythrin (PE)-conjugated anti-b7integrin (M293), allophycocyanin (APC)-
conjugated anti-IL-17RB, APC-Cy7-conjugated anti-c-Kit (2B8), PE-Cy7-con-
jugated anti-CD3e (145-2C11), Horizon V500-conjugated CD4 (RPA-T4), and
biotinylated anti-T1/ST2 (DJ8) antibodies. Subsequently, cells were counter-
stained with PerCP-Cy5.5-conjugated monoclonal antibodies against lineage
(Lin) markers (CD11b [M1/70], CD11c [HL3], CD8 [53-6.7], B220 [RA3-6B2],
Gr-1 [RB6-8C5], and CD335 [NKP46, 29A.4]) and with Brilliant Violet
421-labeled Streptavidin (Biolegend) before analysis with a FACSCanton II
(BD Bioscience) or cell sorting with a FACSAria II (BD Bioscience). For intracel-
lular cytokine analyses, Lin+ LP cells from BALB/c mice were labeled with
microbeads conjugated with monoclonal antibodies against CD4, CD11b,
CD8a, and B220 and then depleted with a MACS column (Miltenyi Biotech).
After re-stimulation with PMA and ionomycin and treatment with Golgi blocker,
enriched Lin LP cells were stained with PE-anti-b7integrin, APC-Cy7-conju-
gated anti-c-Kit, and biotinylated anti-T1/ST2 antibodies. Subsequently, cells
were counterstained with PerCP-Cy5.5-conjugated monoclonal antibodies
against Lin markers (including CD3 and CD4) and with Brilliant Violet 421-
labeled streptavidin. Stained cells were fixed and permeabilized for intracel-
lular cytokine staining using FITC-anti-IFN-g (XMG 1.2) and APC-anti-IL-9
(RM9A4) or APC-anti-IL-13 (eBio13A).
IgE-Mediated Experimental Food Allergy
Mice were sensitized twice within a 2-week interval by intraperitoneal (i.p.) in-
jection with 100 mg OVA and 1 mg alum and then orally gavaged with OVA
(50 mg in 250 ml saline) six times within 2 weeks. In prophylactic experiments,
sensitized BALB/cmicewere injected intraperitoneally with 500 mg anti-FcεRIa
(MAR-1) antibody (Biolegend) or hamster isotype control antibody (Bio X Cell)
or with 500 mg of anti-CD4 (GK1.5) antibody (Bio X Cell) or rat isotype control
antibody (Bio X Cell) twice 1 day before the first and fourth intragastric OVA
challenges. Some antibody-treated mice were rested for 2 weeks after the
sixth OVA challenge before reconstitution with 1 3 106 purified MMC9s by800 Immunity 43, 788–802, October 20, 2015 ª2015 Elsevier Inc.retro-orbital injection. At 1 day after adoptive transfer, mice were re-chal-
lenged with OVA intragastrically, then re-challenged every other day until
they developed allergic diarrhea.
Measurement of Parameters of Food Allergy
Serum samples were analyzed with ELISA kits for OVA-specific IgE (MD
Bioproducts), MCPt-1 (eBioscience), and OVA-specific IgG1 (alpha diagnostic
international). For intestinal histological analyses, duodenal tissue was fixed in
10% formalin and processed by standard histological techniques. 5-mm tissue
sections were stained with Leder stain for chloroacetate esterase (CAE)
activity in intestinal mast cells or periodic acid-Schiff (PAS) for mucins in goblet
cells. Stained cells were quantified as previously described (Brandt et al.,
2003). Assessment of diarrhea and measurement of hyperthermia (rectal
temperature drop > 2C) were performed as previously described (Osterfeld
et al., 2010).
Measurement of Cytokines and Mediators
PurifiedMCPs,MMC9s, and ILC2s (53 104) frommicewith active allergic diar-
rhea were stimulated with PMA (0.1 mg/ml) and ionomycin (1 mg/ml) for 1 day or
with the indicated cytokines for 3 days before the collection of supernatants.
CD4+GFPhi Th2 cells (5 3 104) were stimulated with plate-bound anti-CD3
(5 mg/ml) and soluble anti-CD28 (1 mg/ml) for 24 hr. Secreted cytokines in su-
pernatants were assessed by ELISA kits for IL-5 (R&D), IL-9 (Biolegend), IL-4,
IFN-g, IL-17A (BD Bioscience), and IL-13 (Antigenic American). Secreted
MCPt-1 was measured by ELISA (eBioscience). BMMCs were derived and
degranulation assays were performed as previously described (Arumugam
et al., 2011). Secreted b-hexoaminidase activity wasmeasured by colorimetric
determination with 4-nitrophenyl-N-acetyl-b-D-glucosaminide as described
previously (Arumugam et al., 2011). Histamine content was determined by
ELISA (Beckman Coulter).
Statistical Analysis
Data are presented as the mean ± SEM. Power analysis was performed based
on preliminary datasets to determine the sample sizes, which are large enough
to obtain adequate statistical significance. The inclusion and exclusion criteria
for murine studies were pre-established. For all murine studies, mice were
assigned at random in groups. For the measurement of parameters of food
allergy, studies were performed in a blinded fashion. For comparisons be-
tween groups, statistical significance was determined with a nonparametric,
two-tailed Mann-Whitney t test or unpaired Student’s t test. Correlation anal-
ysis was performed with a nonparametric Spearman correlation (sensitivity
analyses was performed), and a linear regression of the data is displayed.
Statistical tests used for all data are justified as deemed appropriate. Results
are considered significant at p% 0.05. F test was used to compare variances
within each group of data, and Welch’s correction was used, if the variances
were significantly different between groups. All data were analyzed with Prism
(Graphpad Software).
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